These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16872269)

  • 1. Levosalbutamol in the treatment of asthma.
    Milgrom H
    Expert Opin Pharmacother; 2006 Aug; 7(12):1659-68. PubMed ID: 16872269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (R)-salbutamol in the treatment of asthma and chronic obstructive airways disease.
    Patel M; Thomson NC
    Expert Opin Pharmacother; 2011 May; 12(7):1133-41. PubMed ID: 21453221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of levosalbutamol: what are the clinical implications?
    Boulton DW; Fawcett JP
    Clin Pharmacokinet; 2001 Jan; 40(1):23-40. PubMed ID: 11236808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levalbuterol hydrochloride.
    Slattery D; Wong SW; Colin AA
    Pediatr Pulmonol; 2002 Feb; 33(2):151-7. PubMed ID: 11802253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preserved bronchial dilatation after salbutamol does not guarantee protection against bronchial hyperresponsiveness.
    Sjöswärd KN; Josefsson M; Ahlner J; Schmekel B
    Clin Physiol Funct Imaging; 2003 Jan; 23(1):14-20. PubMed ID: 12558609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detrimental effects of albuterol on airway responsiveness requires airway inflammation and is independent of β-receptor affinity in murine models of asthma.
    Lundblad LK; Rinaldi LM; Poynter ME; Riesenfeld EP; Wu M; Aimi S; Barone LM; Bates JH; Irvin CG
    Respir Res; 2011 Mar; 12(1):27. PubMed ID: 21385381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study.
    Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S
    Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levosalbutamol for chronic obstructive pulmonary disease: a treatment evaluation.
    Patel M; Thomson NC
    Expert Opin Pharmacother; 2012 May; 13(7):1069-75. PubMed ID: 22364295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proof-of-concept evaluation of trough airway hyper-responsiveness following regular racemic or levosalbutamol in genotype-stratified steroid-treated persistent asthmatic patients.
    Anderson WJ; Short PM; Williamson PA; Morrison AE; Palmer C; Tavendale R; Lipworth BJ
    Clin Sci (Lond); 2014 Jan; 126(1):75-83. PubMed ID: 23829494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of single doses of S-salbutamol, R-salbutamol, racemic salbutamol, and placebo on the airway response to methacholine.
    Cockcroft DW; Swystun VA
    Thorax; 1997 Oct; 52(10):845-8. PubMed ID: 9404369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients.
    Gawchik SM; Saccar CL; Noonan M; Reasner DS; DeGraw SS
    J Allergy Clin Immunol; 1999 Apr; 103(4):615-21. PubMed ID: 10200010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The asthma-like pharmacology and toxicology of (S)-isomers of beta agonists.
    Handley D
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S69-76. PubMed ID: 10452791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with levalbuterol.
    Nelson HS
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S77-84. PubMed ID: 10452792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence based review on levosalbutamol.
    Gupta MK; Singh M
    Indian J Pediatr; 2007 Feb; 74(2):161-7. PubMed ID: 17337829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levalbuterol and racemic albuterol: are there therapeutic differences?
    Ahrens R; Weinberger M
    J Allergy Clin Immunol; 2001 Nov; 108(5):681-4. PubMed ID: 11692088
    [No Abstract]   [Full Text] [Related]  

  • 16. Levalbuterol in the treatment of patients with asthma and chronic obstructive lung disease.
    Dalonzo GE
    J Am Osteopath Assoc; 2004 Jul; 104(7):288-93. PubMed ID: 15293593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta2-agonist eutomers: a rational option for the treatment of asthma?
    Boulton DW; Fawcett JP
    Am J Respir Med; 2002; 1(5):305-11. PubMed ID: 14720033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenoceptor responses of the airways: for better or worse?
    Broadley KJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Efficacy of Levosalbutamol and Racemic Salbutamol in the Treatment of Acute Exacerbation of Asthma.
    Rabbany MA; Saha BK; Subha N; Sultana I; Islam MS; Hossain AJ; Seraj S; Farzana S; Sharmin M; Ali MM; Nahar A; Siddiqui KA
    Mymensingh Med J; 2023 Jan; 32(1):10-17. PubMed ID: 36594293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.